Rama Phosphates posted robust quarterly and half-year financial results: Q2 Revenue up 17% to ₹245.66 Cr, PAT up 460% to ₹17.28 Cr.

Rama Phosphates LimitedRAMAPHO · Filed with the exchange

Dhule SSP plant trial production by Q4 (₹30.41 Cr CAPEX) on track.

MOP imports and HURL SSP contract renewal drive performance.

ICRA rating reaffirmed.

No comments yet. Be the first.

More from Rama Phosphates Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.